Related Experiment Video
Updated: May 27, 2026

2D-HPLC-MS Technology Combined with Molecular Network for the Identification of Components in Tibetan Medicine Aconitum pendulum
Published on: December 8, 2023
Pharmaceutical study of Lauha Bhasma
1Department of Rasa Shastra, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
This study optimized Lauha Bhasma preparation using an electric muffle furnace (EMF). A temperature of 600°C for 20 puta cycles proved ideal for achieving desired pharmaceutical characteristics.
Area of Science:
- Ayurvedic Pharmaceuticals
- Materials Science
- Traditional Indian Medicine
Background:
- Lauha Bhasma is a traditional Ayurvedic medicine prepared from processed iron.
- Optimizing its pharmaceutical processing is crucial for therapeutic efficacy.
- Traditional methods require precise control over parameters like temperature.
Purpose of the Study:
- To present pharmaceutical processing of Lauha Bhasma.
- To validate the marana process of Lauha using an electric muffle furnace (EMF).
- To determine the ideal temperature for Lauha Bhasma preparation in an EMF.
Main Methods:
- Pharmaceutical processing involved samanya shodhana, vishesha shodhana, and marana of Lauha.
- Marana utilized three techniques: bhanupaka, sthalipaka, and putapaka.
- Putapaka was conducted in an EMF at two temperatures: 800°C (Batch I) and 600°C (Batch II).
Main Results:
- Optimal Lauha Bhasma preparation was achieved after 20 puta cycles at 600°C.
- Desired characteristics, including 'pakwa jambu phala varna' and varitar, were attained at 600°C.
- Processing at 800°C resulted in hard, brassy yellow pellets, requiring temperature reduction.
Conclusions:
- A temperature of 600°C is ideal for Lauha Bhasma preparation using the putapaka method in an EMF.
- The study validates the marana process and establishes optimal conditions for EMF use.
- Controlled temperature is critical for achieving the desired quality of Lauha Bhasma.
Related Concept Videos
Bioequivalence studies: Biowaivers
Bioavailability Study Design: Single Versus Multiple Dose Studies
Clinically Relevant Drug Product Specifications: Methods of Establishment
Modified-Release Drug Delivery Systems: Bioavailability
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence